Firms with manufacturing base in Brazil get priority in state-backed R&D programme
This article was originally published in Scrip
Executive Summary
Pharma and medtech firms with manufacturing facilities in Brazil are being given priority in competitions for state co-funded R&D, under changes to the "production development partnership" (PDP) programme. This and other selection criteria and rules have been enacted by the health ministry through the bill Portaria 837, of 18 April 2012.